| Market Cap | 9.5B 8.34B 7.68B 7.15B 13.49B 903B 13.76B 92.33B 35.77B 443B 35.66B 34.89B 1,543B | P/E 2026 * |
169x | P/E 2027 * | 36.7x |
|---|---|---|---|---|---|
| Enterprise Value | 9.29B 8.15B 7.5B 6.99B 13.19B 883B 13.46B 90.25B 34.97B 433B 34.86B 34.11B 1,508B | EV / Sales 2026 * |
9.23x | EV / Sales 2027 * | 6.45x |
| Free-Float |
65.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Corcept Therapeutics
| 1 day | +0.16% |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
CEO | Chief Executive Officer | 68 | 1998-12-31 |
Atabak Mokari
DFI | Director of Finance/CFO | 49 | 2021-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 48 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
BRD | Director/Board Member | 68 | 1998-12-31 |
Gregg Alton
BRD | Director/Board Member | 60 | 2020-03-11 |
George Baker
BRD | Director/Board Member | 83 | 1998-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | +13.02% | - | - | 9.33B | |
| -0.64% | +6.67% | +53.59% | +154.11% | 1,070B | |
| +0.00% | +5.39% | +62.89% | +53.44% | 611B | |
| -0.23% | +6.88% | +32.14% | +86.34% | 445B | |
| -1.20% | -0.96% | +26.12% | +20.22% | 329B | |
| -1.74% | -0.40% | +33.19% | +22.86% | 290B | |
| -1.25% | +0.53% | +27.68% | +38.89% | 287B | |
| +2.99% | +4.00% | -26.09% | -41.06% | 213B | |
| -0.22% | +2.82% | +24.37% | +62.75% | 195B | |
| -0.29% | +0.65% | +12.75% | +63.45% | 157B | |
| Average | -0.24% | +2.83% | +27.41% | +51.22% | 399.58B | |
| Weighted average by Cap. | -0.41% | +4.14% | +38.21% | +76.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.01B 883M 813M 758M 1.43B 95.65B 1.46B 9.78B 3.79B 46.95B 3.78B 3.7B 163B | 1.4B 1.23B 1.13B 1.05B 1.99B 133B 2.03B 13.61B 5.27B 65.34B 5.26B 5.14B 227B |
| Net income | 85.73M 75.27M 69.28M 64.56M 122M 8.15B 124M 833M 323M 4B 322M 315M 13.92B | 369M 324M 298M 278M 523M 35.04B 534M 3.58B 1.39B 17.2B 1.38B 1.35B 59.86B |
| Net Debt | -213M -187M -172M -161M -303M -20.29B -309M -2.07B -804M -9.96B -801M -784M -34.66B | -474M -416M -383M -357M -673M -45.08B -687M -4.61B -1.79B -22.13B -1.78B -1.74B -77.02B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
